Geno Germano Email

President and CEO . Elucida Oncology

Current Roles

Employees:
24
Revenue:
$3.7M
About
Elucida Oncology, Inc., is a clinical development stage company based on proprietary ultra-small C-Dot technology to find, see and treat an array of solid tumor cancers. Developed and clinically translated by Memorial Sloan-Kettering Cancer Center and Cornell University, C-Dots have published human safety and tumor-specific clinical data. Elucida Oncology is currently progressing through a broad clinical trial program while continuing to drive a future portfolio through ongoing innovation.
Elucida Oncology Address
1 Deer Park Drive
Monmouth Junction, NJ
United States
Elucida Oncology Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.